https://www.selleckchem.com/pr....oducts/beta-nicotina
Moreover, in the intermediate-risk group, local therapy improved PFS only for patients who were associated with post-TURP PSA 4 ng/mL or less then 68% PSA reduction following TURP. We also found that local therapy had no obvious improvement in PFS for those with post-TURP ≤ 4 ng/mL regardless of pre-TURP PSA. In conclusion, conservative management is considered for patients at low or intermediate risk who have greater PSA reduction following TURP and low post-TURP PSA. Therefore, the levels of PSA following
Like
Comment
Share
